RecruitingNot ApplicableNCT06497218
Smartphone-Based Neurobehavioral Assessments as a Diagnostic Aid in Autism
Sponsor
Blinklab Limited
Enrollment
450 participants
Start Date
May 15, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Retrospective case-control study to assess the diagnostic accuracy in autism spectrum disorder (ASD) of a new smartphone-based platform designed to conduct neurometric evaluations by measuring facial and behavioural reflexes.
Eligibility
Min Age: 3 YearsMax Age: 12 Years
Inclusion Criteria4
- Male or female individuals between the ages of 3 - 12 years old at the time of consent.
- Caregiver must be able to read, understand and sign the Informed Consent Form (ICF).
- Normal or corrected-to-normal vision with visual acuity sufficient to watch short videos.
- Hearing adequate to hear the auditory stimuli delivered via headphones.
Exclusion Criteria3
- Participants under 3 or over 12 years old.
- Severe hearing or visual impairment.
- Participants using medication that affects the nervous system (classified as ATC N0 medication, https://www.whocc.no).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTBlinklab diagnostic device
Blinklab is a non-invasive diagnostic device for Autism Spectrum Disorder
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06497218
Related Trials
Promoting Emotional and Autonomic Control Through Guided Breathing Exercises for Emerging Adults With Autism
NCT072381532 locations
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
NCT0559071521 locations
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
NCT065233871 location
DINO RCT - Treating Anxiety in Children With Autism
NCT060669831 location
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
NCT043227342 locations